A detailed history of Edge Capital Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Edge Capital Group, LLC holds 7,597 shares of ABT stock, worth $894,622. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,597
Previous 8,169 7.0%
Holding current value
$894,622
Previous $848,000 2.12%
% of portfolio
0.04%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $57,240 - $67,570
-572 Reduced 7.0%
7,597 $866,000
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $11,986 - $13,380
-119 Reduced 1.44%
8,169 $848,000
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $4,928 - $5,443
-45 Reduced 0.54%
8,288 $942,000
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $124,822 - $152,793
-1,384 Reduced 14.24%
8,333 $917,000
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $4.03 Million - $4.84 Million
-42,230 Reduced 81.29%
9,717 $941,000
Q2 2023

Aug 08, 2023

SELL
$100.78 - $112.29 $42,629 - $47,498
-423 Reduced 0.81%
51,947 $5.66 Million
Q1 2023

May 04, 2023

BUY
$96.86 - $114.01 $2.88 Million - $3.4 Million
29,783 Added 131.86%
52,370 $5.3 Million
Q4 2022

Feb 07, 2023

BUY
$95.06 - $111.52 $1.04 Million - $1.22 Million
10,895 Added 93.18%
22,587 $2.48 Million
Q3 2022

Nov 09, 2022

BUY
$96.76 - $112.03 $72,086 - $83,462
745 Added 6.81%
11,692 $1.13 Million
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $26,538 - $32,076
-260 Reduced 2.32%
10,947 $1.19 Million
Q1 2022

May 03, 2022

SELL
$114.02 - $139.04 $4.81 Million - $5.86 Million
-42,161 Reduced 79.0%
11,207 $1.33 Million
Q4 2021

Jan 19, 2022

SELL
$115.53 - $141.46 $2.17 Million - $2.66 Million
-18,810 Reduced 26.06%
53,368 $7.51 Million
Q3 2021

Oct 26, 2021

SELL
$116.66 - $129.06 $143,958 - $159,260
-1,234 Reduced 1.68%
72,178 $8.53 Million
Q2 2021

Aug 09, 2021

SELL
$105.79 - $124.53 $198,779 - $233,991
-1,879 Reduced 2.5%
73,412 $8.51 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $1.02 Million - $1.2 Million
-9,328 Reduced 11.02%
75,291 $9.02 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $839,370 - $914,673
7,994 Added 10.43%
84,619 $9.27 Million
Q3 2020

Nov 09, 2020

BUY
$91.64 - $111.29 $133,794 - $162,483
1,460 Added 1.94%
76,625 $8.34 Million
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $523,279 - $669,732
-6,834 Reduced 8.33%
75,165 $6.87 Million
Q1 2020

May 08, 2020

BUY
$62.82 - $91.86 $484,593 - $708,608
7,714 Added 10.38%
81,999 $6.47 Million
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $72,543 - $80,757
924 Added 1.26%
74,285 $6.45 Million
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $128,734 - $139,588
-1,573 Reduced 2.1%
73,361 $6.14 Million
Q2 2019

Jul 25, 2019

SELL
$72.88 - $85.0 $1.3 Million - $1.52 Million
-17,900 Reduced 19.28%
74,934 $6.3 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $1.1 Million - $1.33 Million
-16,645 Reduced 15.2%
92,834 $7.42 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $7.18 Million - $8.13 Million
109,479 New
109,479 $7.92 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Edge Capital Group, LLC Portfolio

Follow Edge Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Capital Group, LLC with notifications on news.